RVAC Medicines

Singapore, Singapore

RVAC Medicines is an mRNA platform company with a pipeline of novel products covering a wide range of disease areas.

$140.0M raised

Apr 2022

Series B

Biotechnology Medical Product Research

Top Investors

Pavilion Capital EDBI C-Bridge Capital GS Holdings

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about RVAC Medicines

How much funding has RVAC Medicines raised?

RVAC Medicines has raised $140.0M in total funding. The most recent round was Series B. The last funding was announced in April 2022.

Who are RVAC Medicines's investors?

RVAC Medicines's investors include Pavilion Capital, EDBI, C-Bridge Capital, GS Holdings.

Where is RVAC Medicines headquartered?

RVAC Medicines is headquartered in Singapore, Singapore.

What does RVAC Medicines do?

RVAC Medicines is an mRNA platform company with a pipeline of novel products covering a wide range of disease areas.

What stage is RVAC Medicines at?

RVAC Medicines is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 26, 2022.

MLA

"RVAC Medicines — Funding & Investors." VCBacked, April 26, 2022, https://www.vcbacked.co/company/rvac-medicines. Accessed July 2, 2026.

APA

VCBacked. (2022). RVAC Medicines — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/rvac-medicines

Wikipedia (cite web)

{{cite web |title=RVAC Medicines — Funding & Investors |url=https://www.vcbacked.co/company/rvac-medicines |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 26, 2022.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K